Hikma Pharmaceuticals, Societe de Promotion deal

Hikma launched its mandatory tender offer to acquire the remaining 36.1% of the pharmaceutical manufacturing company it does not already own for MAD1,155 ($138.14) per share. In October, Hikma acquire...